17β-Estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5467-5479

  Jayaraman, Anusha ^a   Carroll, Jenna C ^a   Morgan, Todd E ^a   Lin, Sharon ^a   Zhao, Liqin ^a   Arimoto, Jason M ^a   Murphy, M Paul ^b   Beckett, Tina L ^b   Finch, Caleb E ^a   Brinton, Roberta Diaz ^a   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; ESTRADIOL; MEMBRANE METALLOENDOPEPTIDASE; PROGESTERONE; SEX HORMONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL LEVEL; FEMALE; IN VIVO STUDY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK;

AMYLOID BETA-PEPTIDES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; CELLS, CULTURED; ESTRADIOL; FEMALE; INSULYSIN; METALLOENDOPEPTIDASES; NEPRILYSIN; NEURONS; PEPTIDYL-DIPEPTIDASE A; PREALBUMIN; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867776138     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1464     Document Type: Article

References (79)

1. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A 1999 Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52:78-84
2. Pike CJ, Carroll JC, Rosario ER, Barron AM 2009 Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30:239-258
3. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR 1992 Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42:115-119
4. Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh- Sørensen P 1999 Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study. Neurology 52: 85-90
5. Sohrabji F 2008 Premenopausal oophorectomy and the risk for dementia. Womens Health (Lond Engl) 4:127-131
6. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H 2004 The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann NY Acad Sci 1019: 24-28
7. Henderson VW, Buckwalter JG 1994 Cognitive deficits of men and women with Alzheimer's disease. Neurology 44:90-96
8. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA 2005 Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685-691
9. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R 2000 Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54:833-837
10. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ 2011 Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32:604-613
11. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R 2005 Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 102:19198-19203
12. Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen F, Schröder J, Schönknecht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J 2008 Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging 29:812-818
13. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Donnell Lingle D, Metter E 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology [Erratum (1998) 51:564]48:1517-1521
14. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129
15. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones III BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
16. Singh M, Sumien N, Kyser C, Simpkins JW 2008 Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci 13:1083-1089
17. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K 2011 Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 69:163-169
18. Selkoe DJ 1994 Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol 4:708-716
19. Petanceska SS, Nagy V, Frail D, Gandy S 2000 Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Exp Gerontol 35:1317-1325
20. Levin-Allerhand JA, Lominska CE, Wang J, Smith JD 2002 17Alpha- estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AβPPSWE transgenic mice. J Alzheimers Dis 4:449-457
21. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ 2007 Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27: 13357-13365
22. Carroll JC, Rosario ER, Villamagna A, Pike CJ 2010 Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology 151:2713-2722
23. Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Meittinen R, Puoliväli J 2004 Estrogen treatment improves spatial learning in APP+PS1 mice but does not affect β amyloid accumulation and plaque formation. Exp Neurol 187:105-117
24. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE 1994 Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 269:13065-13068
25. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S 1998 Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 4:447-451
26. Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS 2007 Accelerated Aβ deposition in APPswe/PS1δE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 27:7006-7010
27. Leissring MA 2008 The AβCs of Aβ-cleaving proteases. J Biol Chem 283:29645-29649
28. Mukherjee A, Song E, Kihiko-Ehmann M, Goodman Jr JP, Pyrek JS, Estus S, Hersh LB 2000 Insulysin hydrolyzes amyloid β peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci 20:8745-8749
29. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ 2000 Neurons regulate extracellular levels of amyloid β-protein via proteolysis by Insulin-degrading enzyme. J Neurosci 10:1657-1665
30. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL 2003 Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221-6226
31. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ 2003 Endoplasmic reticulum-localized amyloid β-peptide is degraded in the cytosol by two distinct degradation pathways. Neuron 40:1087-1093
32. Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC 2001 Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon- sensitive endopeptidases. J Biol Chem 276:21895-21901
33. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC 2001 Metabolic regulation of brain Aβ by neprilysin. Science 292:1550-1552
34. Kanemitsu H, Tomiyama T, Mori H 2003 Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350: 113-116
35. Wang S, Wang R, Chen L, Bennett DA, Dickson DW, Wang DS 2010 Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 115:47-57
36. Eckman EA, Reed DK, Eckman CB 2001 Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme. J Biol Chem 276:24540-24548
37. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB 2003 Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278:2081-2084
38. Hemming ML, Selkoe DJ 2005 Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280:37644-37650
39. Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, Gong JS, Yu W, Yamamoto T, Kosaka K, Yanagisawa K, Michikawa M 2007 Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ(1- 42)) to Aβ(1- 40), and its inhibition enhances brain Aβ deposition. J Neurosci 27:8628-8635
40. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T 2008 Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity. Proc Natl Acad Sci USA 105:2681-2686
41. Pike CJ 1999 Estrogen modulates neuronal Bcl-xL expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72:1552-1563
42. Figueiredo HF, Ulrich-Lai YM, Choi DC, Herman JP 2007 Estrogen potentiates adrenocortical responses to stress in female rats. Am J Physiol Endocrinol Metab 292:E1173-E1182
43. Jayaraman A, Pike CJ 2009 Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 21:77-81
44. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:402-408
45. Beckett TL, Niedowicz DM, Studzinski CM, Weidner AM, Webb RL, Holler CJ, Ahmed RR, LeVine III H, Murphy MP 2010 Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle. Neurobiol Dis 39:449-456
46. Wakeling AE, Bowler J 1992 ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Mol Biol 43:173-177
47. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α- selective agonists. J Med Chem 43:4934-4947
48. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251
49. Schreiber JR, Hsueh AJ, Baulieu EE 1983 Binding of the anti-progestin RU-486 to rat ovary steroid receptors. Contraception 28: 77-85
50. Kloosterboer HJ, Schoonen WG, Deckers GH, Klijn JG 1994 Effects of progestagens and OrgOD14 in in vitro and in vivo tumor models. J Steroid Biochem Mol Biol 49:311-318
51. Hardy J, Selkoe DJ 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
52. Gandy S, Petanceska S 2001 Regulation of Alzheimer β-amyloid precursor trafficking and metabolism. Adv Exp Med Biol 487:85-100
53. Udrisar DP, Wanderley MI, Porto RC, Cardodo CL, Barbosa MC, Canberos MC, Cresto JC 2005 Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus. Exp Biol Med (Maywood) 230:479-486
54. Zhao L, Yao J, Mao Z, Chen S, Wang Y, Brinton RD 2010 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 32:1949-1963
55. Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P 2008 Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor- α knock-out mice. Exp Physiol 93:658-664
56. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB 1999 Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33:323-328
57. Seltzer A, Pinto JE, Viglione PN, Correa FM, Libertun C, Tsutsumi K, Steele MK, Saavedra JM 1992 Estrogens regulate angiotensinconverting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 55:460-467
58. Dean SA, Tan J, O'Brien ER, Leenen FH 2005 17β-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 288:R759-R766
59. Proudler AJ, Cooper A, Whitehead M, Stevenson JC 2003 Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women. Clin Endocrinol (Oxf) 58:30-35
60. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K 2001 Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity. Atherosclerosis 158:391-397
61. Keator CS, Mah K, Ohm L, Slayden OD 2011 Estrogen and progesterone regulate expression of the endothelins in the rhesus macaque endometrium. Hum Reprod 26:1715-1728.
62. Rodrigo MC, Martin DS, Eyster KM 2003 Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 73:2973-2983
63. Neves LA, Chappell MC, Ferrario CM, Gallagher PE, Ganten D, Brosnihan KB 2006 Effect of estrogen on neprilysin expression in uterus and kidney of Sprague-Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats. Peptides 27:2912-2918
64. Huang J, Guan H, Booze RM, Eckman CB, Hersh LB 2004 Estrogen regulates neprilysin activity in rat brain. Neurosci Lett 367:85-87
65. Liang K, Yang L, Yin C, Xiao Z, Zhang J, Liu Y, Huang J 2010 Estrogen stimulates degradation of β-amyloid peptide by up-regulating neprilysin. J Biol Chem 285:935-942
66. Xiao ZM, Sun L, Liu YM, Zhang JJ, Huang J 2009 Estrogen regulation of the neprilysin gene through a hormone-responsive element. J Mol Neurosci 39:22-26
67. Quintela T, Gonçalves I, Baltazar G, Alves CH, Saraiva MJ, Santos CR 2009 17β-Estradiol induces transthyretin expression in murine choroid plexus via an oestrogen receptor dependent pathway. Cell Mol Neurobiol 29:475-483
68. Tang YP, Haslam SZ, Conrad SE, Sisk CL 2004 Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid β scavenger protein. J Alzheimers Dis 6:413-420; discussion 443-449
69. Amtul Z, Wang L, Westaway D, Rozmahel RF 2010 Neuroprotective mechanism conferred by 17β-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169:781-786
70. Wang JM, Singh C, Liu L, Irwin RW, Chen S, Chung EJ, Thompson RF, Brinton RD 2010 Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 107:6498-6503
71. Chen S, Wang JM, Irwin RW, Yao J, Liu L, Brinton RD 2011 Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease. PLoS One 6:e24293
72. Gao H, Yallampalli U, Yallampalli C 2012 Protein restriction to pregnant rats increases the plasma levels of angiotensin II and expression of angiotensin II receptors in uterine arteries. Biol Reprod 86:68
73. Casey ML, Smith JW, Nagai K, Hersh LB, MacDonald PC 1991 Progesterone-regulated cyclic modulation of membrane metalloendopeptidase (enkephalinase) in human endometrium. J Biol Chem 266:23041-23047
74. Strom JO, Theodorsson A, Theodorsson E 2009 Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J Cereb Blood Flow Metab 29:1359-1372
75. Gibbs RB 2000 Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101: 931-938
76. Zhao L, Morgan TE, Mao Z, Lin S, Cadenas E, Finch CE, Pike CJ, Mack WJ, Brinton RD 2012 Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One 7:e31267
77. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T 2005 MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942
78. Mannella P, Brinton RD 2006 Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci 26:9439-9447
79. Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM 2004 Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J Neurosci 24:11120-11126